Engineering Dendritic Cells to Treat Cancer (Part 1) | Guardian Bio

from Nucleate Podcast · host Ananya Zutshi, Ricky Barrett, Sam Kessel

Origin Stories and path to Biotech [00:00]Taking the leap to entrepreneurship [07:30]The formation story of Guardian Bio [20:25]The methodical process Ananya used to identify a co-founder [26:00]The core thesis of Guardian Bio- Dendritic Cells for Solid Tumors [29:00]The key pivots Guardian made early on [34:15]

Episode metadata supplied by the publisher feed · Published Aug 12, 2024

Embed this episode

Attribution link and audio player

What this episode covers

In this episode of the Nucleate Podcast, we are joined by Ananya Zutshi and Ricky Barrett, founders of Guardian Bio, a Boston-based biotech company (and Nucleate Alumni). Their platform focuses on engineering dendritic cells to target solid tumors. We delve into the ups and downs of their entrepreneurial journey, the unique dynamic between co-founders, and their advice for communicating complex science topics.

Distinct summary based on available episode metadata or transcript content.

Ready to play

Engineering Dendritic Cells to Treat Cancer (Part 1) | Guardian Bio

0:00 39:54

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

#207 13 actionable pieces of mental health advice from six former podcast guests

Dec 12, 2025 ·53m

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Nucleate Podcast?

This episode is 39 minutes long.

When was this Nucleate Podcast episode published?

This episode was published on August 12, 2024.

Can I download this Nucleate Podcast episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!